Press releases prior to August 2023 are from EIP Pharma, Inc., a wholly-owned subsidiary of CervoMed, Inc.

CervoMed to Participate in the Emerging Growth Conference 67
BOSTON , Feb. 05, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced that Company’s Management will provide a corporate update at the Emerging Growth Conference 67, to be held
February 5, 2024
PDF Version
CervoMed to Participate in the Emerging Growth Conference 66
BOSTON , Jan. 05, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced that Company’s Management will provide a corporate update at the Emerging Growth Conference 66, to be held
January 5, 2024
PDF Version
Displaying 31 - 32 of 32